advanced search

Welcome: Guest

log in

Victhom Human Bionics Inc. Product Pipeline Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 37
ISBN Number not applicable
Product Code GMD04755
Price

£400.00
approximately: $747 | €507

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Victhom Human Bionics Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
  • 3 Victhom Human Bionics Inc. Pipeline Products
    • 3.1 Victhom Human Bionics Inc. Product Pipeline Analysis
      • 3.1.1 Victhom Human Bionics Inc. Pipeline Products By Equipment Type
      • 3.1.2 Victhom Human Bionics Inc. Pipeline Products By Development Stage
      • 3.1.3 Victhom Human Bionics Inc. Pipeline Products By Therapy Area
      • 3.1.4 Victhom Human Bionics Inc. Pipeline Products By Clinical Trials
      • 3.1.5 Victhom Human Bionics Inc. Pipeline Products By News Summary
    • 3.2 Bionic Orthosis
      • 3.2.1 Product Description
      • 3.2.2 Product Status
      • 3.2.3 Product Milestone
    • 3.3 Bionized CLS
      • 3.3.1 Product Description
      • 3.3.2 Product Status
    • 3.4 Neurostep
      • 3.4.1 Product Description
      • 3.4.2 Product Status
      • 3.4.3 Clinical Trials
      • 3.4.4 Product Milestone
    • 3.5 NeuroCuff
      • 3.5.1 Product Description
      • 3.5.2 Product Status
    • 3.6 Neurosensing Platform
      • 3.6.1 Product Description
      • 3.6.2 Product Status
    • 3.7 Urinary disorders implant
      • 3.7.1 Product Description
      • 3.7.2 Product Status
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Major Products and Services
      • 4.2.1 Overview
  • 5 History
  • 6 Competitors
  • 7 Key Employees
  • 8 Key Employee Biographies
  • 9 Company Statement
  • 10 Locations And Subsidiaries
    • 10.1 Head Office
  • 11 Financial Deals Landscape
    • 11.1 Venture Financing
      • 11.1.1 Victhom Human Bionics raises $5 million from Solidarity Fund QFL
  • 12 Recent Developments
    • 12.1 Financial Announcements
      • 12.1.1 Nov 12, 2007: Victhom Reports Q3 2007 Results
      • 12.1.2 Aug 10, 2007: Victhom Reports Q2 2007 Results
      • 12.1.3 May 11, 2007: Victhom Reports Q1 2007 Results
      • 12.1.4 Mar 26, 2007: Victhom Reports Q4 2006 Results
    • 12.2 Other Significant Developments
      • 12.2.1 Apr 04, 2008: Victhom Announces Departure Of Its President And CEO
      • 12.2.2 Nov 12, 2007: Victhom Appoints New Board Member
      • 12.2.3 Apr 17, 2007: Victhom Appoints New COO
      • 12.2.4 Apr 05, 2007: Victhom Appoints New Director
  • 13 Appendix
    • 13.1 Methodology
      • 13.1.1 Coverage
      • 13.1.2 Secondary Research
      • 13.1.3 Primary Research
      • 13.1.4 Expert Panel Validation
    • 13.2 Contact Us
    • 13.3 About Global Markets Direct
    • 13.4 Disclaimer
  • List of Tables
    • Table 1: Victhom Human Bionics Inc.,Key Facts
    • Table 2: Victhom Human Bionics Inc. Pipeline Products by Equipment Type
    • Table 3: Victhom Human Bionics Inc. Pipeline Products By Development Stage
    • Table 4: Victhom Human Bionics Inc. Pipeline Products By Therapy Area
    • Table 5: Victhom Human Bionics Inc. Pipeline Products By Clinical Trials
    • Table 6: Victhom Human Bionics Inc. Pipeline Products By News Summaries
    • Table 7: Victhom Human Bionics Inc., Key Employees,
  • List of Figures
    • Figure 1: Victhom Human Bionics Inc. Pipeline Products By News Summary
    • Figure 2: Global Markets Direct Methodology